Relapsed Refractory Extensive Stage Small Cell Lung Cancer Es Sclc clinical trials

Explore recruiting relapsed refractory extensive stage small cell lung cancer es sclc clinical trials.

Recruiting relapsed refractory extensive stage small cell lung cancer es sclc studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Relapsed Refractory Extensive Stage Small Cell Lung Cancer Es Sclc trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

DAREONTM-9: A study to test how well different doses of BI 764532 are tolerated by people with small cell lung cancer when taken together with a single agent chemotherapy

Germany, France, Poland

Human Pharmacology (Phase I)- Other EU CTIS Study details

Relapsed Refractory Extensive Stage Small Cell Lung Cancer Es Sclc trials by city

Relapsed Refractory Extensive Stage Small Cell Lung Cancer Es Sclc in Toronto Relapsed Refractory Extensive Stage Small Cell Lung Cancer Es Sclc in Vancouver Relapsed Refractory Extensive Stage Small Cell Lung Cancer Es Sclc in Montreal Relapsed Refractory Extensive Stage Small Cell Lung Cancer Es Sclc in Calgary Relapsed Refractory Extensive Stage Small Cell Lung Cancer Es Sclc in Edmonton Relapsed Refractory Extensive Stage Small Cell Lung Cancer Es Sclc in Ottawa Relapsed Refractory Extensive Stage Small Cell Lung Cancer Es Sclc in Winnipeg Relapsed Refractory Extensive Stage Small Cell Lung Cancer Es Sclc in Quebec City Relapsed Refractory Extensive Stage Small Cell Lung Cancer Es Sclc in Hamilton Relapsed Refractory Extensive Stage Small Cell Lung Cancer Es Sclc in Kitchener Relapsed Refractory Extensive Stage Small Cell Lung Cancer Es Sclc in London Relapsed Refractory Extensive Stage Small Cell Lung Cancer Es Sclc in Halifax Relapsed Refractory Extensive Stage Small Cell Lung Cancer Es Sclc in New York Relapsed Refractory Extensive Stage Small Cell Lung Cancer Es Sclc in Los Angeles Relapsed Refractory Extensive Stage Small Cell Lung Cancer Es Sclc in Chicago Relapsed Refractory Extensive Stage Small Cell Lung Cancer Es Sclc in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease